LIH scientist wins €1.5m ERC grant

Résumé

This funding announcement reports on an ERC (European Research Council) grant awarded to Dr Ángel Álvarez-Prado at Luxembourg Institute of Health (LIH) for research on ageing, genetics, and brain cancer treatment. The grant totals €1.5 million and is aimed at developing personalised therapeutic approaches. Note: this appears to be a news announcement of an already-awarded grant rather than an open call for applications.

This is a past award announcement for an individual researcher's ERC grant in brain cancer and personalized medicine, not an open funding call. Acme Corporation (a semiconductor/AI company) is ineligible as the call targets academic researchers, and the scientific domain (oncology/neuroscience) is entirely outside the client's industry and strategic priorities.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

Dr Ángel Álvarez-Prado studies how ageing and genetics influence brain cancer, with the aim of developing more personalised treatments.